Chapter 14 Cell Death Pathways in Amyotrophic Lateral Sclerosis

Blue Books of Practical Neurology

Volumn 28, Issue C, 2003, Pages 357-377

  Przedborski, Serge ^a   Clarke, Peter G H ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77957162904     PISSN: 18773419     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1877-3419(09)70115-1     Document Type: Article

References (103)

1. Clarke P.G.H. Developmental cell death: morphological diversity and multiple mechanisms. Anat Embryol 181 (1990) 195-213
2. Clarke P.G.H. Apoptosis Versus Necrosis. In: Koliatsos V.E., and Ratan R.R. (Eds). Cell Death and Diseases of the Nervous System (1999), Humana Press, New Jersey 3-28
3. Kerr J.F.R., Wyllie A.H., and Currie A.R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26 (1972) 239-257
4. Sloviter R.S. Apoptosis: a guide for the perplexed. Trends Pharmacol Sci 23 (2002) 19-24
5. Bursch W. The autophagosomal-lysosomal compartment in programmed cell death. Cell Death Differ 8 (2001) 569-581
6. Uchiyama Y. Autophagic cell death and its execution by lysosomal cathepsins [review]. Arch Histol Cytol 64 (2001) 233-246
7. Xue L.Z., Fletcher G.C., and Tolkovsky A.M. Autophagy is activated by apoptotic signaling in sympathetic neurons: an alternative mechanism of death execution. Mol Cell Neurosci 14 (1999) 180-198
8. Kitanaka C., and Kuchino Y. Caspase-independent programmed cell death with necrotic morphology. Cell Death Differ 6 (1999) 508-515
9. Castagné V., Gautschi M., Lefèvre K., et al. Relationships between neuronal death and the cellular redox status. Focus on the developing nervous system. Prog Neurobiol 59 (1999) 397-423
10. Lefèvre K., Clarke P.G.H., Danthe E.E., and Castagné V. Involvement of cyclin-dependent kinases in axotomy-induced retinal ganglion cell death. J Comp Neurol 447 (2002) 72-81
11. Sperandio S.d.B., and Bredesen D.E. An alternative, nonapoptotic form of programmed cell death. Proc Natl Acad Sci USA 97 (2000) 14376-14381
12. Wyllie A.H., Kerr J.F., and Currie A.R. Cell death: the significance of apoptosis. Int Rev Cytol 68 (1980) 251-306
13. Moroni F., Meli E., Peruginelli F., et al. Poly(ADP-ribose) polymerase inhibitors attenuate necrotic but not apoptotic neuronal death in experimental models of cerebral ischemia. Cell Death Differ 8 (2001) 921-932
14. Borsello T., Bonny C., Riederer B.M., and Clarke P.G.H. Cell-permeable peptides inhibit JNK action, and completely protect neurons from NMDA-induced necrotic death. Soc Neurosci Abstr 27 (2001) 215-267
15. Hayward N.J., Elliott P.J., Sawyer S.D., et al. Lack of evidence for neutrophil participation during infarct formation following focal cerebral ischemia in the rat. Exp Neurol 139 (1996) 188-202
16. Pilar G., and Landmesser L. Ultrastructural differences during embryonic cell death in normal and peripherally deprived ciliary ganglia. J Cell Biol 68 (1976) 339-356
17. Cuadros M.A., Martin D., Pérez-Mendoza D., et al. Response of macrophage/microglial cells to experimental neuronal degeneration in the avian isthmo-optic nucleus during development. J Comp Neurol 423 (2000) 659-669
18. Blaschke A.J., Weiner J.A., and Chun J. Programmed cell death is a universal feature of embryonic and postnatal neuroproliferative regions throughout the central nervous system. J Comp Neurol 396 (1998) 39-50
19. Burek M.J., and Oppenheim R.W. Cellular Interactions that Regulate Programmed Cell Death in the Developing Vertebrate Nervous System. In: Koliatsos V.E., and Ratan R.R. (Eds). Cell Death and Diseases of the Nervous System (1999), Humana Press, New Jersey 145-179
20. Knyihar E., Csillik B., and Rakic P. Transient synapses in the embryonic primate spinal cord. Science 202 (1978) 1206-1209
21. Catsicas M., Péquignot Y., and Clarke P.G.H. Rapid onset of neuronal death induced by blockade of either axoplasmic transport or action potentials in afferent fibers during brain development. J Neurosci 12 (1992) 4642-4650
22. von Bartheld C.S. Neurotrophins in the developing and regenerating visual system. Histol Histopathol 13 (1998) 437-459
23. Alcantara S., Frisen J., del Rio J.A., et al. TrkB signaling is required for postnatal survival of CNS neurons and protects hippocampal and motor neurons from axotomy-induced cell death. J Neurosci 17 (1997) 3623-3633
24. Woolley A., Sheard P., Dodds K., and Duxson M. Alpha motoneurons are present in normal numbers but with reduced soma size in neurotrophin-3 knockout mice. Neurosci Lett 272 (1999) 107-110
25. von Bartheld C.S., and Johnson J.E. Target-derived BDNF (brain-derived neurotrophic factor) is essential for the survival of developing neurons in the isthmo-optic nucleus. J Comp Neurol 433 (2001) 550-564
26. Thoenen H. Neurotrophins and activity-dependent plasticity. Prog Brain Res 128 (2000) 183-191
27. Oppenheim R.W., Prevette D., D'Costa A., et al. Reduction of neuromuscular activity is required for the rescue of motoneurons from naturally occurring cell death by nicotinic-blocking agents. J Neurosci 20 (2000) 6117-6124
28. M-P P., and Clarke P.G.H. Presynaptic initiation by action potentials of retrograde signals in developing neurons. J Neurosci 17 (1997) 4253-4261
29. Li L.X., Wu W.T., Lin L.F.H., et al. Rescue of adult mouse motoneurons from injury-induced cell death by glial cell line-derived neurotrophic factor. Proc Natl Acad Sci USA 92 (1995) 9771-9775
30. Eisen A., and Weber M. Treatment of amyotrophic lateral sclerosis [review]. Drugs Aging 14 (1999) 173-196
31. Apfel S.C. Neurotrophic factor therapy-prospects and problems. Clin Chem Lab Med 39 (2001) 351-355
32. Russell F.D., Koishi K., Jiang Y., and McLennan I.S. Anterograde axonal transport of glial cell line-derived neurotrophic factor and its receptors in rat hypoglossal nerve. Neuroscience 97 (2000) 575-580
33. Rowland L.P. Hereditary and Acquired Motor Neuron Diseases. In: Rowland L.P. (Ed). Merritt's Textbook of Neurology (1995), Williams & Wilkins, Philadelphia 742-749
34. H-X D., Hentati A., Tainer J.A., et al. Amyotrophic lateral sclerosis and structural defects in Cu, Zn superoxide dismutase. Science 261 (1993) 1047-1051
35. Rosen D.R., Siddique T., Patterson D., et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362 (1993) 59-62
36. Brown Jr. R.H. Amyotrophic lateral sclerosis: recent insights from genetics and transgenic mice. Cell 80 (1995) 687-692
37. Przedborski S., Donaldson D., Murphy P.L., et al. Blood superoxide dismutase, catalase and glutathione peroxidase activities in familial and sporadic amyotrophic lateral sclerosis. Neurodegeneration 5 (1996) 57-64
38. Troy C.M., and Shelanski M.L. Down-regulation of copper/zinc superoxide dismutase causes apoptotic death in PC12 neuronal cells. Proc Natl Acad Sci USA 91 (1994) 6384-6387
39. Rothstein J.D., Bristol L.A., Hosler B., et al. Chronic inhibition of superoxide dismutase produces apoptotic death of spinal neurons. Proc Natl Acad Sci USA 91 (1994) 4155-4159
40. Reaume A.G., Elliott J.L., Hoffman E.K., et al. Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nat Genet 13 (1996) 43-47
41. Gurney M.E., Pu H., Chiu A.Y., et al. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science 264 (1994) 1772-1775
42. Wong P.C., Pardo C.A., Borchelt D.R., et al. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 14 (1995) 1105-1116
43. Bruijn L.I., Becher M.W., Lee M.K., et al. ALS-linked SOD1 mutant G85R mediated damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron 18 (1997) 327-338
44. Nagai M., Aoki M., Miyoshi I., et al. Rats expressing human cytosolic copper-zinc superoxide dismutase transgenes with amyotrophic lateral sclerosis: associated mutations develop motor neuron disease. J Neurosci 21 (2001) 9246-9254
45. Subramaniam J.R., Lyons W.E., Liu J., et al. Mutant SOD1 causes motor neuron disease independent of copper chaperone-mediated copper loading. Nat Neurosci 5 (2002) 301-307
46. Brown Jr. R.H. Superoxide dismutase in familial amyotrophic lateral sclerosis: models for gain of function. Curr Opin Neurobiol 5 (1995) 841-846
47. Rabizadeh S., Gralla E.B., Borchelt D.R., et al. Mutations associated with amyotrophic lateral sclerosis convert superoxide dismutase from an antiapoptotic gene to a proapoptotic gene: studies in yeast and neural cells. Proc Natl Acad Sci USA 92 (1995) 3024-3028
48. Ghadge G.D., Lee J.P., Bindokas V.P., et al. Mutant superoxide dismutase-1-linked familial amyotrophic lateral sclerosis: molecular mechanisms of neuronal death and protection. J Neurosci 17 (1997) 8756-8766
49. Mena M.A., Khan U., Togasaki D.M., et al. Effects of wild-type and mutated copper/zinc superoxide dismutase on neuronal survival and l-DOPA-induced toxicity in postnatal midbrain culture. J Neurochem 69 (1997) 21-33
50. Kostic V., Jackson-Lewis V., De Bilbao F., et al. Bcl-2: Prolonging life in a transgenic mouse model of familial amyotrophic lateral sclerosis. Science 277 (1997) 559-562
51. Li M., Ona V.O., Guegan C., et al. Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model. Science 288 (2000) 335-339
52. Cleveland D.W., and Rothstein J.D. From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat Rev Neurosci 2 (2001) 806-819
53. Hirano A. Aspects of the ultrastructure of amyotrophic lateral sclerosis. Adv Neurol 36 (1982) 75-88
54. Martin L.J. Neuronal death in amyotrophic lateral sclerosis is apoptosis: possible contribution of a programmed cell death mechanism. J Neuropathol Exp Neurol 58 (1999) 459-471
55. Mitsumoto H., Chad D.A., and Pioro E.P. Amyotrophic lateral sclerosis (1998), FA Davis, Philadelphia 285-302
56. Mitsumoto H., and Bradley W.G. Murine motor neuron disease (the Wobbler mouse): degeneration and regeneration of the lower motor neuron. Brain 105 pt 4 (1982) 811-834
57. Divers T.J., Mohammed H.O., and Cummings J.F. Equine motor neuron disease. Vet Clin North Am Equine Pract 13 (1997) 97-105
58. Dal Canto M.C., and Gurney M.E. Neuropathological changes in two lines of mice carrying a transgene for mutant human Cu, Zn SOD, and in mice overexpressing wild type human SOD: a model of familial amyotrophic lateral sclerosis (FALS). Brain Res 676 (1995) 25-40
59. Migheli A., Atzori C., Piva R., et al. Lack of apoptosis in mice with ALS. Nat Med 5 (1999) 966-967
60. Pasinelli P., Houseweart M.K., Brown Jr. R.H., and Cleveland D.W. Caspase-1 and -3 are sequentially activated in motor neuron death in Cu, Zn superoxide dismutase-mediated familial amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 97 (2000) 13901-13906
61. Vukosavic S., Stefanis L., Jackson-Lewis V., et al. Delaying caspase activation by Bcl-2: a clue to disease retardation in a transgenic mouse model of amyotrophic lateral sclerosis. J Neurosci 20 (2000) 9119-9125
62. Chiu A.Y., Zhai P., Dal Canto M.C., et al. Age-dependent penetrance of disease in a transgenic mouse model of familial amyotrophic lateral sclerosis. Mol Cell Neurosci 6 (1995) 349-362
63. Yoshiyama Y., Yamada T., Asanuma K., and Asahi T. Apoptosis related antigen, Le(Y) and nick-end labeling are positive in spinal motor neurons in amyotrophic lateral sclerosis. Acta Neuropathol (Berl) 88 (1994) 207-211
64. Ekegren T., Grundstrom E., Lindholm D., and Aquilonius S.M. Upregulation of Bax protein and increased DNA degradation in ALS spinal cord motor neurons. Acta Neurol Scand 100 (1999) 317-321
65. Migheli A., Cavalla P., Marino S., and Schiffer D. A study of apoptosis in normal and pathologic nervous tissue after in situ end-labeling of DNA strand breaks. J Neuropathol Exp Neurol 53 (1994) 606-616
66. He B.P., and Strong M.J. Motor neuronal death in sporadic amyotrophic lateral sclerosis (ALS) is not apoptotic. A comparative study of ALS and chronic aluminium chloride neurotoxicity in New Zealand white rabbits. Neuropathol Appl Neurobiol 26 (2000) 150-160
67. Hiraishi K., Suzuki K., Hakomori S., and Adachi M. Le(y) antigen expression is correlated with apoptosis (programmed cell death). Glycobiology 3 (1993) 381-390
68. Suurmeijer A.J., van der Wijk J., van Veldhuisen D.J., et al. Fractin immunostaining for the detection of apoptotic cells and apoptotic bodies in formalin-fixed and paraffin-embedded tissue. Lab Invest 79 (1999) 619-620
69. Rangnekar V.M. Apoptosis mediated by a novel leucine zipper protein Par-4. Apoptosis 3 (1998) 61-66
70. Pedersen W.A., Luo H., Kruman I., et al. The prostate apoptosis response-4 protein participates in motor neuron degeneration in amyotrophic lateral sclerosis. FASEB J 14 (2000) 913-924
71. Harper S.J., and LoGrasso P. Signaling for survival and death in neurones-The role of stress-activated kinases, JNK and p38. Cell Signal 13 (2001) 299-310
72. Gupta S. Molecular steps of death receptor and mitochondrial pathways of apoptosis. Life Sci 69 (2001) 2957-2964
73. Raoul C., Estevez A., Nishimune H., et al. Motoneuron death triggered by a specific pathway downstream of Fas. Potentiation by ALS-linked SOD1 mutations. Neuron 35 (2002) 1067
74. Kong J.M., and Xu Z.S. Massive mitochondrial degeneration in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SOD1. J Neurosci 18 (1998) 3241-3250
75. Browne S.E., Bowling A.C., Baik M.J., et al. Metabolic dysfunction in familial, but not sporadic, amyotrophic lateral sclerosis. J Neurochem 71 (1998) 281-287
76. Kroemer G., and Reed J.C. Mitochondrial control of cell death. Nat Med 6 (2000) 513-519
77. Warita H., Manabe Y., Murakami T., et al. Early decrease of survival signal-related proteins in spinal motor neurons of presymptomatic transgenic mice with a mutant SOD1 gene. Apoptosis 6 (2001) 345-352
78. Almer G., Vukosavic S., Romero N., and Przedborski S. Inducible nitric oxide synthase upregulation in a transgenic mouse model of familial amyotrophic lateral sclerosis. J Neurochem 72 (1999) 2415-2425
79. Alexianu M.E., Kozovska M., and Appel S.H. Immune reactivity in a mouse model of familial ALS correlates with disease progression. Neurology 57 (2001) 1282-1289
80. Nguyen M.D., Julien J.P., and Rivest S. Induction of proinflammatory molecules in mice with amyotrophic lateral sclerosis: no requirement for proapoptotic interleukin-1beta in neurodegeneration. Ann Neurol 50 (2001) 630-639
81. Chao D.T., and Korsmeyer S.J. Bcl-2 family: regulators of cell death. Annu Rev Immunol 16 (1998) 395-419
82. Merry D.E., and Korsmeyer S.J. Bcl-2 gene family in the nervous system. Annu Rev Neurosci 20 (1997) 245-267
83. J-C M., Dubois-Dauphin M., Staple J.K., et al. Overexpression of bcl-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia. Neuron 13 (1994) 1017-1030
84. Parsadanian A.S., Cheng Y., Keller-Peck C.R., et al. Bcl-xL is an antiapoptotic regulator for postnatal CNS neurons. J Neurosci 18 (1998) 1009-1019
85. Deckwerth T.L., Elliott J.L., Knudson C.M., et al. Bax is required for neuronal death after trophic factor deprivation and during development. Neuron 17 (1996) 401-411
86. Mu X., He J., Anderson D.W., et al. Altered expression of bcl-2 and bax mRNA in amyotrophic lateral sclerosis spinal cord motor neurons. Ann Neurol 40 (1996) 379-386
87. Vukosavic S., Dubois-Dauphin M., Romero N., and Przedborski S. Bax and Bcl-2 interaction in a transgenic mouse model of familial amyotrophic lateral sclerosis. J Neurochem 73 (1999) 2460-2468
88. Troost D., Aten J., Morsink F., and De Jong J.M.B.V. Apoptosis in amyotrophic lateral sclerosis is not restricted to motor neurons. Bcl-2 expression is increased in unaffected post-central gyrus. Neuropathol Appl Neurobiol 21 (1995) 498-504
89. Gonzalez de Aguilar J.L., Gordon J.W., Rene F., et al. Alteration of the Bcl-x/Bax ratio in a transgenic mouse model of amyotrophic lateral sclerosis: evidence for the implication of the p53 signaling pathway. Neurobiol Dis 7 (2000) 406-415
90. Guégan C., Vila M., Rosoklija G., et al. Recruitment of the mitochondrial-dependent apoptotic pathway in amyotrophic lateral sclerosis. J Neurosci 21 (2001) 6569-6576
91. Guégan C., Vila M., Teismann P., et al. Instrumental activation of Bid by caspase-1 in a transgenic mouse model of ALS. Mol Cell Neurosci 20 (2002) 553-562
92. Shinoe T., Wanaka A., Nikaido T., et al. Upregulation of the pro-apoptotic BH3-only peptide harakiri in spinal neurons of amyotrophic lateral sclerosis patients. Neurosci Lett 313 (2001) 153-157
93. Miyashita T., Krajewski S., Krajewska M., et al. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9 (1994) 1799-1805
94. Appella E., and Anderson C.W. Post-translational modifications and activation of p53 by genotoxic stresses. Eur J Biochem 268 (2001) 2764-2772
95. Martin L.J. p53 is abnormally elevated and active in the CNS of patients with amyotrophic lateral sclerosis. Neurobiol Dis 7 (2000) 613-622
96. Prudlo J., Koenig J., Graser J., et al. Motor neuron cell death in a mouse model of FALS is not mediated by the p53 cell survival regulator. Brain Res 879 (2000) 183-187
97. Kaufmann S.H., and Hengartner M.O. Programmed cell death: alive and well in the new millennium. Trends Cell Biol 11 (2001) 526-534
98. Pasinelli P., Borchelt D.R., Houseweart M.K., et al. Caspase-1 is activated in neural cells and tissue with amyotrophic lateral sclerosis-associated mutations in copper-zinc superoxide dismutase. Proc Natl Acad Sci USA 95 (1998) 15763-15768
99. Friedlander R.M., Brown R.H., Gagliardini V., et al. Inhibition of ICE slows ALS in mice. Nature 388 (1997) 31
100. Nakagawa T., Zhu H., Morishima N., et al. Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta. Nature 403 (2000) 98-103
101. Bergeron L., Perez G.I., Macdonald G., et al. Defects in regulation of apoptosis in caspase-2-deficient mice. Genes Dev 12 (1998) 1304-1314
102. Zhu S., Stavrovskaya I., Drozda M., et al. Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature 417 (2002) 74-78
103. Zheng T.S., Hunot S., Kuida K., et al. Deficiency in caspase-9 or caspase-3 induces compensatory caspase activation. Nat Med 6 (2000) 1241-1247